Literature DB >> 8704227

Risk of hepatitis C virus infection, Waldenström's macroglobulinemia, and monoclonal gammopathies.

F Silvestri, G Barillari, R Fanin, F Zaja, L Infanti, F Patriarca, M Baccarani, C Pipan, E Falasca, G A Botta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8704227

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  Hepatitis C virus infection in patients with essential mixed cryoglobulinemia, multiple myeloma and chronic lymphocytic leukemia.

Authors:  S Gharagozloo; J Khoshnoodi; F Shokri
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

Review 2.  Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options.

Authors:  Gabriele Pozzato; Cesare Mazzaro; Luigino Dal Maso; Endri Mauro; Francesca Zorat; Giulia Moratelli; Pietro Bulian; Diego Serraino; Valter Gattei
Journal:  World J Hepatol       Date:  2016-01-18

3.  Waldenstrom macroglobulinemia.

Authors:  Xavier Leleu; Aldo M Roccaro; Anne-Sophie Moreau; Sophie Dupire; Daniela Robu; Julie Gay; Evdoxia Hatjiharissi; Nicholas Burwik; Irene M Ghobrial
Journal:  Cancer Lett       Date:  2008-06-13       Impact factor: 8.679

Review 4.  Hepatitis c and lymphoma.

Authors:  F Silvestri; A Sperotto; R Fanin
Journal:  Curr Oncol Rep       Date:  2000-03       Impact factor: 5.945

5.  Waldenström macroglobulinemia in hepatitis C: case report and review of the current literature.

Authors:  Ryan Nipp; Aaron Mitchell; Allyson Pishko; Ara Metjian
Journal:  Case Rep Oncol Med       Date:  2014-08-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.